Lobbying Spend
—
Filings
10
Firms Hired
1
Active Period
2014–2016
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Saving Access to Compounded Medications for Special Needs Patients Act
2016 · first_quarter · Firm: ROCK & ASSOCIATES
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: — · Firm income: —
Matched citations: S.1406
Saving Access to Compounded Medications for Special Needs Patients Act
2015 · fourth_quarter · Firm: ROCK & ASSOCIATES
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: — · Firm income: $11,250
Matched citations: S.1406
Saving Access to Compounded Medications for Special Needs Patients Act
2015 · third_quarter · Firm: ROCK & ASSOCIATES
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: — · Firm income: —
Matched citations: S.1406
Saving Access to Compounded Medications for Special Needs Patients Act
2015 · second_quarter · Firm: ROCK & ASSOCIATES
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: — · Firm income: $11,250
Matched citations: S.1406
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015
2014 · fourth_quarter · Firm: ROCK & ASSOCIATES
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S. 2437.
Client expense: — · Firm income: $11,250
Matched citations: S. 2437
A bill to amend title XVIII of the Social Security Act to permit direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump.
2014 · fourth_quarter · Firm: ROCK & ASSOCIATES
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. S. 914, Legislation to permit pharmacies to bill Medicare directly for compounded drugs that are prepared for a specific individual for use through an implanted un-fusion pump.
Client expense: — · Firm income: $11,250
Matched citations: S. 914
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015
2014 · third_quarter · Firm: ROCK & ASSOCIATES
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S.2437.
Client expense: — · Firm income: $11,250
Matched citations: S.2437
A bill to amend title XVIII of the Social Security Act to permit direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump.
2014 · third_quarter · Firm: ROCK & ASSOCIATES
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. S.914, Legislation to permit pharmacies to bill Medicare directly for compounded drugs that are prepared for a specific individual for use though an implanted infusion pump.
Client expense: — · Firm income: $11,250
Matched citations: S.914
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015
2014 · second_quarter · Firm: ROCK & ASSOCIATES
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S.2437.
Client expense: — · Firm income: —
Matched citations: S.2437
Source: Senate LDA